N/A
N=869
An Epidemiology Survey on the Incidence of Perioperative Hypothermia
Hypothermia
Bottom Line
View on ClinicalTrials.gov: NCT01913041 ↗Enrolled (actual)
869
Serious AEs
0.0%
Results posted
Jun 2014
Primary outcome: Primary: The Incidence of Perioperative Hypothermia — 39.8 Percentage of hypothermia participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Jie YI
- Primary completion
- Nov 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Incidence of Perioperative Hypothermia |
39.8 | — |
Summary
* The purpose of this study is to understand and grasp the incidence rate of hypothermia during perioperative period of elective operations under general anaesthesia in Beijing.
* The purpose of this study is to carry out a subgroup analysis on the survey data and explore the high-risk factors for the incidence of hypothermia.
Eligibility Criteria
Inclusion Criteria
- Male or female, no limitation on age
- Subject who will undergo elective surgery with general anaesthesia
- The duration of surgery is expected to be over 40 minutes
- The subject agreed to participate in the study and signed the informed
Exclusion Criteria
- Central high fever caused by enter nerves system disease or condition, including that induced by cerebrovascular disease, cerebral trauma, cerebral surgeries, epilepsy and acute hydrocephalus
- Thermoregulation abnormalities including malignant hyperthermia (MHS) and neuroleptic malignant syndrome, hypothyroidism or hyperthyroidism diagnosed by substantial evidence
- Infectious fever
- Patients whose core temperature is higher than 38.5°C within 7 days before surgery
- Diseases or that may lead to inaccuracy in measurement, such as ear infection
- Surgeries with active cooling process during operation
Data sourced from ClinicalTrials.gov (NCT01913041). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.